Leading biotech company in China, Innovent Biologics has announced the completion of its $150 million Ser...
Zoetis Inc. recently started the construction of a combined global manufacturing and supply and research and development...
STA Pharmaceutical Co., Ltd., a subsidiary of WuXi AppTec (WuXi STA), has signed an investment agreement with the govern...
Werfen, a global leader in healthcare and life sciences, achieves revenues of 1,337 million euros in 2017, a 1...
Foundation Medicine, Inc. (FM), F. Hoffmann-La Roche Ltd (Roche) and DIAN Diagnostics Group, Co., Ltd. (DIAN), have anno...
Singapore – Shanghai-based Zai Lab Limited inks an exclusive license agreement with privately held Entasis Therape...
MilliporeSigma, a leader in genome editing, has announced that the Chinese Patent Office has issued a notice granting Mi...
Singapore- Tocagen enters into a license agreement with ApolloBio affiliate Beijing Apollo Venus Biomedical Te...
Prenetics, a HongKong-based genetic testing and digital health company, has announced acquisition of DNAFit, a UK-based ...
Sinovac Biotech, a leading provider of biopharmaceutical products in China, has announced preliminary results of a phase...
WuXi AppTec is a leading global pharmaceutical and medical device open-access capability and technology platform company...
JHL Biotech recently announced that the China Food and Drug Administration (CFDA) have accepted for review JHL's Clinica...
Royal Philips, a global leader in health technology, and Digital China Health, the largest provider of cloud-based healt...
AK Medical Holdings, a Beijing orthopedic implant maker, has paid $24 million to acquire JRI Orthopedics, UK.&...
CMB International Capital Corporation Ltd, a wholly-owned subsidiary of China Merchants Bank, recently led a $65 million...
Morphotek Inc., a subsidiary of Eisai Inc., has licensed its eribulin-linker payload to Bliss Biopharmaceutical Co., Ltd...
China-based BeiGene, , a commercial-stage biopharmaceutical company focused on developing and commercializing inno...
Ubiquigent Limited has entered into a multi-year strategic R&D collaboration agreement with FORMA Therapeutics for t...
